A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells
- 1 December 1994
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 372 (6505) , 467-470
- https://doi.org/10.1038/372467a0
Abstract
THE enzyme DNA topoisomerase II, which removes the caten-ations formed between the DNA molecules of sister chromatids during replication1 and is a structural component of chromosome cores2 , is needed for chromosome condensation in yeast3 and in Xenopus extracts4–6. Inhibitors of topoisomerase II arrest mam-malian cells before mitosis in the G2 phase of the cell cycle7, but also produce DNA damage, which causes arrest through established checkpoint controls8. It is open to question whether cells need topoisomerase II to leave G2, or control late-cycle progres-sion in response to its activity. Bisdioxopiperazines are topoisomerase II inhibitors that act without producing direct DNA damage9; the most potent, ICRF-193, blocks mammalian entry into but not exit from mitosis. Here we show that checkpoint-evading agents such as caffeine override this block to produce abortively condensed chromosomes, indicating that topoisomerase II is needed for complete condensation. We find that exit from G2 is regulated by a catenation-sensitive checkpoint mechanism which is distinct from the G2-damage checkpoint.Keywords
This publication has 23 references indexed in Scilit:
- Antitumor bisdioxopiperazines inhibit yeast DNAtopoisomerase II by trapping the enzyme in the form of a closed proteinclamp.Proceedings of the National Academy of Sciences, 1994
- Topoisomerase II does not play a scaffolding role in the organization of mitotic chromosomes assembled in Xenopus egg extracts.The Journal of cell biology, 1993
- The nucleoskeleton and the topology of replicationCell, 1991
- Chemically induced premature mitosis: differential response in rodent and human cells and the relationship to cyclin B synthesis and p34cdc2/cyclin B complex formation.Proceedings of the National Academy of Sciences, 1991
- Chromosome assembly in vitro: Topoisomerase II is required for condensationCell, 1991
- Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II.The Journal of cell biology, 1990
- Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells.The EMBO Journal, 1990
- DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombeCell, 1987
- Mode of Action of the Cytostatic Agent ‘ICRF 159’Nature, 1970
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969